ID   GAK_HUMAN               Reviewed;        1311 AA.
AC   O14976; Q9BVY6;
DT   29-AUG-2001, integrated into UniProtKB/Swiss-Prot.
DT   29-AUG-2001, sequence version 2.
DT   02-NOV-2010, entry version 108.
DE   RecName: Full=Cyclin-G-associated kinase;
DE            EC=2.7.11.1;
GN   Name=GAK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CHARACTERIZATION.
RC   TISSUE=Fibroblast;
RX   MEDLINE=97446136; PubMed=9299234; DOI=10.1006/geno.1997.4873;
RA   Kimura S.H., Tsuruga H., Yabuta N., Endo Y., Nojima H.;
RT   "Structure, expression, and chromosomal localization of human GAK.";
RL   Genomics 44:179-187(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 981-1311.
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   MEDLINE=20092914; PubMed=10625686; DOI=10.1074/jbc.275.2.1365;
RA   Greener T., Zhao X., Nojima H., Eisenberg E., Greene L.E.;
RT   "Role of cyclin G-associated kinase in uncoating clathrin-coated
RT   vesicles from non-neuronal cells.";
RL   J. Biol. Chem. 275:1365-1370(2000).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16; SER-456; SER-770;
RP   SER-780; SER-826; SER-829; SER-834 AND SER-1096, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-826; SER-829 AND
RP   SER-834, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16; SER-326; TYR-615;
RP   THR-776; SER-778; SER-780; THR-805; SER-815; SER-817; SER-826;
RP   SER-829; SER-834; SER-837; SER-838; SER-939; SER-1070; SER-1073;
RP   SER-1176 AND SER-1185, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-826 AND SER-829, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [9]
RP   VARIANTS [LARGE SCALE ANALYSIS] LEU-144; MET-580; TYR-787; ARG-877;
RP   ASP-962; MET-1051; HIS-1120; LEU-1137; ASN-1168; ARG-1265 AND
RP   ASN-1297.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Associates with cyclin G and CDK5. Seems to act as an
CC       auxilin homolog that is involved in the uncoating of clathrin-
CC       coated vesicles by Hsc70 in non-neuronal cells. Expression
CC       oscillates slightly during the cell cycle, peaking at G1.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, perinuclear region. Golgi
CC       apparatus, trans-Golgi network. Cell junction, focal adhesion
CC       (Probable). Note=Localizes to the perinuclear area and to the
CC       trans-Golgi network. Also seen on the plasma membrane, probably at
CC       focals adhesions.
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Highest in testis.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr
CC       protein kinase family.
CC   -!- SIMILARITY: Contains 1 C2 tensin-type domain.
CC   -!- SIMILARITY: Contains 1 J domain.
CC   -!- SIMILARITY: Contains 1 phosphatase tensin-type domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D88435; BAA22623.1; -; mRNA.
DR   EMBL; BC000816; AAH00816.1; -; mRNA.
DR   EMBL; BC008668; AAH08668.1; -; mRNA.
DR   IPI; IPI00298949; -.
DR   RefSeq; NP_005246.2; -.
DR   UniGene; Hs.369607; -.
DR   PDB; 3LL6; X-ray; 2.10 A; A/B=12-347.
DR   PDBsum; 3LL6; -.
DR   ProteinModelPortal; O14976; -.
DR   SMR; O14976; 406-705, 1139-1311.
DR   IntAct; O14976; 18.
DR   STRING; O14976; -.
DR   PhosphoSite; O14976; -.
DR   PRIDE; O14976; -.
DR   Ensembl; ENST00000314167; ENSP00000314499; ENSG00000178950.
DR   GeneID; 2580; -.
DR   KEGG; hsa:2580; -.
DR   UCSC; uc003gbm.2; human.
DR   CTD; 2580; -.
DR   GeneCards; GC04M000832; -.
DR   H-InvDB; HIX0004007; -.
DR   HGNC; HGNC:4113; GAK.
DR   HPA; HPA027405; -.
DR   HPA; HPA027459; -.
DR   HPA; HPA027463; -.
DR   MIM; 602052; gene.
DR   PharmGKB; PA28528; -.
DR   eggNOG; prNOG17535; -.
DR   HOGENOM; HBG446617; -.
DR   HOVERGEN; HBG004322; -.
DR   InParanoid; O14976; -.
DR   OMA; LRIINAN; -.
DR   PhylomeDB; O14976; -.
DR   BRENDA; 2.7.11.1; 247.
DR   Reactome; REACT_11123; Membrane Trafficking.
DR   NextBio; 10201; -.
DR   ArrayExpress; O14976; -.
DR   Bgee; O14976; -.
DR   CleanEx; HS_GAK; -.
DR   Genevestigator; O14976; -.
DR   GermOnline; ENSG00000178950; Homo sapiens.
DR   GO; GO:0005925; C:focal adhesion; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0031072; F:heat shock protein binding; IEA:InterPro.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; TAS:ProtInc.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   InterPro; IPR008973; C2_Ca/lipid-bd_dom_CaLB.
DR   InterPro; IPR001623; DnaJ_N.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR014019; Phosphatase_tensin-typ.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR014020; Tensin_phosphatase_C2-dom.
DR   Gene3D; G3DSA:1.10.287.110; DnaJ_N; 1.
DR   Pfam; PF00226; DnaJ; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF10409; PTEN_C2; 1.
DR   SMART; SM00271; DnaJ; 1.
DR   SUPFAM; SSF49562; C2_CaLB; 1.
DR   SUPFAM; SSF46565; DnaJ_N; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS51182; C2_TENSIN; 1.
DR   PROSITE; PS00636; DNAJ_1; FALSE_NEG.
DR   PROSITE; PS50076; DNAJ_2; 1.
DR   PROSITE; PS51181; PPASE_TENSIN; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; FALSE_NEG.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Cell cycle; Cell junction;
KW   Complete proteome; Cytoplasm; Golgi apparatus; Kinase;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1   1311       Cyclin-G-associated kinase.
FT                                /FTId=PRO_0000085958.
FT   DOMAIN       40    314       Protein kinase.
FT   DOMAIN      399    566       Phosphatase tensin-type.
FT   DOMAIN      572    710       C2 tensin-type.
FT   DOMAIN     1247   1311       J.
FT   COMPBIAS    347    350       Poly-Pro.
FT   ACT_SITE    173    173       Proton acceptor (By similarity).
FT   MOD_RES      16     16       Phosphoserine.
FT   MOD_RES     326    326       Phosphoserine.
FT   MOD_RES     456    456       Phosphoserine.
FT   MOD_RES     615    615       Phosphotyrosine.
FT   MOD_RES     770    770       Phosphoserine.
FT   MOD_RES     776    776       Phosphothreonine.
FT   MOD_RES     778    778       Phosphoserine.
FT   MOD_RES     780    780       Phosphoserine.
FT   MOD_RES     805    805       Phosphothreonine.
FT   MOD_RES     815    815       Phosphoserine.
FT   MOD_RES     817    817       Phosphoserine.
FT   MOD_RES     826    826       Phosphoserine.
FT   MOD_RES     829    829       Phosphoserine.
FT   MOD_RES     834    834       Phosphoserine.
FT   MOD_RES     837    837       Phosphoserine.
FT   MOD_RES     838    838       Phosphoserine.
FT   MOD_RES     939    939       Phosphoserine.
FT   MOD_RES    1070   1070       Phosphoserine.
FT   MOD_RES    1073   1073       Phosphoserine.
FT   MOD_RES    1096   1096       Phosphoserine.
FT   MOD_RES    1176   1176       Phosphoserine.
FT   MOD_RES    1185   1185       Phosphoserine.
FT   VARIANT     144    144       S -> L.
FT                                /FTId=VAR_040505.
FT   VARIANT     580    580       V -> M (in dbSNP:rs34255232).
FT                                /FTId=VAR_040506.
FT   VARIANT     787    787       D -> Y (in dbSNP:rs34585705).
FT                                /FTId=VAR_040507.
FT   VARIANT     877    877       Q -> R.
FT                                /FTId=VAR_040508.
FT   VARIANT     962    962       G -> D (in a lung neuroendocrine
FT                                carcinoma sample; somatic mutation).
FT                                /FTId=VAR_040509.
FT   VARIANT    1051   1051       T -> M (in dbSNP:rs35227944).
FT                                /FTId=VAR_040510.
FT   VARIANT    1120   1120       Q -> H (in dbSNP:rs55801437).
FT                                /FTId=VAR_040511.
FT   VARIANT    1137   1137       P -> L (in dbSNP:rs56169884).
FT                                /FTId=VAR_040512.
FT   VARIANT    1168   1168       S -> N (in dbSNP:rs56326341).
FT                                /FTId=VAR_040513.
FT   VARIANT    1265   1265       K -> R (in dbSNP:rs2306242).
FT                                /FTId=VAR_040514.
FT   VARIANT    1297   1297       D -> N (in dbSNP:rs1134921).
FT                                /FTId=VAR_040515.
FT   CONFLICT   1113   1113       P -> A (in Ref. 1; BAA22623).
SQ   SEQUENCE   1311 AA;  143191 MW;  0ACE45DF57A5F981 CRC64;
     MSLLQSALDF LAGPGSLGGA SGRDQSDFVG QTVELGELRL RVRRVLAEGG FAFVYEAQDV
     GSGREYALKR LLSNEEEKNR AIIQEVCFMK KLSGHPNIVQ FCSAASIGKE ESDTGQAEFL
     LLTELCKGQL VEFLKKMESR GPLSCDTVLK IFYQTCRAVQ HMHRQKPPII HRDLKVENLL
     LSNQGTIKLC DFGSATTISH YPDYSWSAQR RALVEEEITR NTTPMYRTPE IIDLYSNFPI
     GEKQDIWALG CILYLLCFRQ HPFEDGAKLR IVNGKYSIPP HDTQYTVFHS LIRAMLQVNP
     EERLSIAEVV HQLQEIAAAR NVNPKSPITE LLEQNGGYGS ATLSRGPPPP VGPAGSGYSG
     GLALAEYDQP YGGFLDILRG GTERLFTNLK DTSSKVIQSV ANYAKGDLDI SYITSRIAVM
     SFPAEGVESA LKNNIEDVRL FLDSKHPGHY AVYNLSPRTY RPSRFHNRVS ECGWAARRAP
     HLHTLYNICR NMHAWLRQDH KNVCVVHCMD GRAASAVAVC SFLCFCRLFS TAEAAVYMFS
     MKRCPPGIWP SHKRYIEYMC DMVAEEPITP HSKPILVRAV VMTPVPLFSK QRSGCRPFCE
     VYVGDERVAS TSQEYDKMRD FKIEDGKAVI PLGVTVQGDV LIVIYHARST LGGRLQAKMA
     SMKMFQIQFH TGFVPRNATT VKFAKYDLDA CDIQEKYPDL FQVNLEVEVE PRDRPSREAP
     PWENSSMRGL NPKILFSSRE EQQDILSKFG KPELPRQPGS TAQYDAGAGS PEAEPTDSDS
     PPSSSADASR FLHTLDWQEE KEAETGAENA SSKESESALM EDRDESEVSD EGGSPISSEG
     QEPRADPEPP GLAAGLVQQD LVFEVETPAV LPEPVPQEDG VDLLGLHSEV GAGPAVPPQA
     CKAPSSNTDL LSCLLGPPEA ASQGPPEDLL SEDPLLLASP APPLSVQSTP RGGPPAAADP
     FGPLLPSSGN NSQPCSNPDL FGEFLNSDSV TVPPSFPSAH SAPPPSCSAD FLHLGDLPGE
     PSKMTASSSN PDLLGGWAAW TETAASAVAP TPATEGPLFS PGGQPAPCGS QASWTKSQNP
     DPFADLGDLS SGLQGSPAGF PPGGFIPKTA TTPKGSSSWQ TSRPPAQGAS WPPQAKPPPK
     ACTQPRPNYA SNFSVIGARE ERGVRAPSFA QKPKVSENDF EDLLSNQGFS SRSDKKGPKT
     IAEMRKQDLA KDTDPLKLKL LDWIEGKERN IRALLSTLHT VLWDGESRWT PVGMADLVAP
     EQVKKHYRRA VLAVHPDKAA GQPYEQHAKM IFMELNDAWS EFENQGSRPL F
//
